Eduardo Nagore

13.8k total citations · 1 hit paper
301 papers, 6.0k citations indexed

About

Eduardo Nagore is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Eduardo Nagore has authored 301 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Oncology, 128 papers in Dermatology and 90 papers in Epidemiology. Recurrent topics in Eduardo Nagore's work include Cutaneous Melanoma Detection and Management (134 papers), Nonmelanoma Skin Cancer Studies (70 papers) and Melanoma and MAPK Pathways (45 papers). Eduardo Nagore is often cited by papers focused on Cutaneous Melanoma Detection and Management (134 papers), Nonmelanoma Skin Cancer Studies (70 papers) and Melanoma and MAPK Pathways (45 papers). Eduardo Nagore collaborates with scholars based in Spain, Germany and Italy. Eduardo Nagore's co-authors include Celia Requena, Rajiv Kumar, Rafael Botella‐Estrada, Kari Hemminki, P. Sivaramakrishna Rachakonda, V. Través, Dirk Schadendorf, C. Guillén, Adina Figl and C. Serra‐Guillén and has published in prestigious journals such as Science, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eduardo Nagore

290 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TERT Promoter Mutations in Familial and Sporadic Melanoma

2013 1.3k citations Susanne Horn, Adina Figl et al. Science profile →

Peers

Countries citing papers authored by Eduardo Nagore

Since Specialization

Citations

This map shows the geographic impact of Eduardo Nagore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Nagore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Nagore more than expected).

Fields of papers citing papers by Eduardo Nagore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Nagore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Nagore. The network helps show where Eduardo Nagore may publish in the future.

Co-authorship network of co-authors of Eduardo Nagore

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Nagore. A scholar is included among the top collaborators of Eduardo Nagore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Nagore. Eduardo Nagore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secondary Intention Healing Time of Postoperative Surgical Cancer Skin Wounds With a Biosynthetic Porcine Type I Collagen Dressing: A 306-Patient Retrospective, Observational Study 2025 ·Actas Dermo-Sifiliográficas ·Aírton Abrahão Martin, María Roca, (unknown), María Hernández, (unknown), (unknown), Eduardo Nagore	1
2	[Translated article] Avelumab to treat Merkel cell carcinoma: real-life experience in a dedicated oncology center 2024 ·Actas Dermo-Sifiliográficas ·(unknown), (unknown), (unknown), Eduardo Nagore, Celia Requena, Onofre Sanmartín, B. Llombart	1
3	Ultraviolet light-induced collagen degradation inhibits melanoma invasion 2021 ·Nature Communications ·Timothy Budden, Caroline Gaudy‐Marqueste, Andrew P. Porter, Emily Kay, (unknown), Charles H. Earnshaw, (unknown), Sarah Craig, V. Través, Jean Krutmann, Patricia Müller, (unknown), Sara Zanivan, Angeliki Malliri, Simon J. Furney, Eduardo Nagore, Amaya Virós	53
4	Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma Development 2021 ·Cancers ·(unknown), María Peña-Chilet, Zaida García‐Casado, (unknown), Celia Requena, José Bañuls, José Antonio López‐Guerrero, (unknown), V. Través, Joaquı́n Dopazo, Amaya Virós, Rajiv Kumar, Eduardo Nagore	7
5	Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study 2021 ·European Journal of Cancer ·Alicia Barreiro, (unknown), Sebastián Podlipnik, Cristina Carrera, Celia Requena, (unknown), Pietro Quaglino, (unknown), Ane Jaka, (unknown), José Luis Rodríguez‐Peralto, Pablo L. Ortiz‐Romero, Aram Boada, Simone Ribero, Eduardo Nagore, Josep Malvehy, Susana Puig	12
6	Prognostic Role of Non-Identification of Sentinel Lymph Node in Cutaneous Melanoma Patients: An Observational Retrospective Study 2020 ·Cancers ·(unknown), (unknown), Celia Requena, (unknown), V. Través, (unknown), Eduardo Nagore	2
7	Association of HERV-K and LINE-1 Hypomethylation with Reduced Disease-Free Survival in Melanoma Patients 2020 ·Epigenomics ·Maurizio Cardelli, Remco van Doorn, (unknown), (unknown), Francesco Piacenza, Elisa Pierpaoli, Robertina Giacconi, Marco Malavolta, P. Sivaramakrishna Rachakonda, Nelleke A. Gruis, Anders Molven, Per Arne Andresen, Dace Pjanova, Joost J. van den Oord, Mauro Provinciali, Eduardo Nagore, Rajiv Kumar	13
8	Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis 2020 ·Journal of the European Academy of Dermatology and Venereology ·Aram Boada, A. Tejera‐Vaquerizo, Simone Ribero, Susana Puig, D. Moreno‐Ramírez, Simona Osella‐Abate, Paola Cassoni, Josep Malvehy, Sebastián Podlipnik, Celia Requena, (unknown), J.J. Ríos-Martín, Carlos Ferrándiz, Eduardo Nagore, (unknown)	5
9	Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies 2019 ·PLoS Genetics ·(unknown), Ruth M. Pfeiffer, Eduardo Nagore, Susana Puig, Donato Calista, Paola Ghiorzo, Chiara Menin, Maria Concetta Fargnoli, Ketty Peris, Lei Song, Tongwu Zhang, Jianxin Shi, Maria Teresa Landi, Joshua N. Sampson	11
10	Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Anne Ε. Cust, Kristen Pickles, Chris Goumas, (unknown), Helen Schmid, Eduardo Nagore, John W. Kelly, Joanne F. Aitken, Graham G. Giles, John L. Hopper, Mark A. Jenkins, Graham J. Mann	12
11	TERT Promoter Mutations in Familial and Sporadic Melanoma breakdown → 2013 ·Science ·Susanne Horn, Adina Figl, P. Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, (unknown), Iris Moll, Eduardo Nagore, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar	1267
12	High immunohistochemical nestin expression is associated with greater depth of infiltration in dermatofibrosarcoma protuberans: a study of 71 cases 2013 ·Journal of Cutaneous Pathology ·C. Serra‐Guillén, B. Llombart, Eduardo Nagore, Celia Requena, V. Través, (unknown), (unknown), (unknown), Carlos Guillén, Onofre Sanmartín	10
13	Association between markers of aggressiveness of malignant cutaneous melanoma and sleep disordered-breathing 2013 ·European Respiratory Journal ·Francisco Campos‐Rodríguez, Miguel Ángel Martínez‐García, Antonio Martorell, Amalia Pérez‐Gil, Eduardo Nagore, (unknown), (unknown), (unknown), Pedro Landete, Josep M. Montserrat, (unknown), Ramón Farré	1
14	Metastatic Lesions with and without Interleukin-18–Dependent Genes in Advanced-Stage Melanoma Patients 2013 ·American Journal Of Pathology ·Olatz Crende, Marianna Sabatino, María Valcárcel, Teresa Carrascal, Pía Riestra, José Antonio López‐Guerrero, Eduardo Nagore, Susanna Mandruzzato, Ena Wang, Francesco M. Marincola, Fernando Vidal‐Vanaclocha	11
15	Características del melanoma en el momento del diagnóstico en el registro nacional de melanoma cutáneo: 15 años de experiencia ? 2013 ·Actas Dermo-Sifiliográficas ·(unknown), Eduardo Nagore, (unknown), Manuel Martín González, (unknown), (unknown)	1
16	Liquen plano anular y atrófico 2010 ·Revista Medicina Cutánea Ibero-Latino-Americana ·A. Alfaro‐Rubio, Rafael Botella‐Estrada, C. Serra‐Guillén, Celia Requena, Eduardo Nagore, L. Hueso, B. Llombart, O. Sanmartín, C. Guillén	0
17	Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects 2010 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), (unknown), C. Serra‐Guillén, Concepción Gimeno, J.J. Vilata, C. Guillén, Eduardo Nagore	22
18	Colagenosis perforante reactiva adquirida. Dos casos en pacientes diabéticas 2001 ·Anales de Pediatría Continuada ·(unknown), Eduardo Nagore, (unknown), (unknown)	2
19	Pseudoquiste auricular bilateral: presentación de un caso y revisión de la literatura 1999 ·Actas Dermo-Sifiliográficas ·(unknown), Eduardo Nagore, (unknown), (unknown), (unknown), (unknown)	1
20	Fibroma periungueal solitario: ¿se puede descartar la existencia de una esclerosis tuberosa? 1998 ·Actas Dermo-Sifiliográficas ·Eduardo Nagore, José María Sánchez, José M. Fortea, Adolfo Aliaga	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact